1. Sulphasalazine and the aminosalicylates in the treatment of inflammatory bowel disease;Riley, S.A.; Turnberg, L.A.;QuartJ Med,1990
2. A controlled therapeutic trial oflong-tein maintenance treatment ofulcerative colitis with sulphasalazine;Dissanayake, A.S.; Truelove, S.C.,1973
3. Tange JD. Nephrotoxic lesions from 5-aminosalicylic acid;Calder IC, Funder CC, Greein CR, Ham KN;BMJ,1972
4. Steady-state kinetics of 5-aminosalicylic acid and sulphapyridine during sulphasalazine prophylaxis in ulcerative colitis;Bondesen, S.; Nielsen, O.H.; Schou, J.B.;Scand J Gastroenterol,1986
5. Microalbuminuria as a predictor of clinical diabetic nephropathy;Mogensen, C.E.;Kidney Int,1987